EU for Evibodies
By Kate McDonald
Monday, 09 February, 2009
Monday, 09 February, 2009
Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.
Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.
Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.
They were given a US patent in 2007.
Related News
Scientists 'reprogram' tumour-supporting immune cells
The approach, by an Australian team, uses lipid nanoparticles to target a type of immune cell...
Existing medicines could help treat deadly childhood dementia
Australian researchers have identified several existing TGA‑approved medicines that could help...
Statins reduce heart attack and stroke risk in older people
It has previously been unclear whether statins were effective in reducing heart attack and stroke...
